Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial. - Böhm M; Butler J; Mahfoud F; Filippatos G; Ferreira JP; Pocock SJ; Slawik J; Brueckmann M; Linetzky B; Schüler E; Wanner C; Zannad F; et al. (European journal of heart failure, 2022)